PROTOCOLprotocol_logs·May 8, 2026 at 09:27 AM
KPV oral inflammation research protocol
B
BiotinBro
ADVANCED · P2
22
PepT1-mediated transport gives KPV functional oral bioavailability. Tripeptide is rapidly metabolized so multiple daily doses are needed to maintain exposure.
The IBD model literature uses similar dosing patterns.
PROTOCOL PARAMETERS
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| KPV | 500mcg | 3x daily | Oral |
Duration:8 weeks
Goals:Anti-inflammatory research leveraging PepT1 oral transport
RELATED COMPOUNDS
Comments (0)
No comments yet. Start the thread.
Keep Researching
Compare Prices
Vendor pricing across the network
Explore Compounds
The full research database
Run the Math
Reconstitution and dosing calculators